CRDF - CIK 0001213037
The table below shows Cardiff Oncology, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.47M | $51.47M | $21.66M | $16.35M | $11.94M | $130.98M |
| Short-term investments | $40.83M | $40.28M | $53.17M | $88.92M | $128.88M | - |
| Receivables | $182.00K | $773.00K | $288.00K | $771.00K | $535.00K | $320.46K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $60.13M |
| $95.05M |
| $77.41M |
| $111.28M |
| $146.13M |
| $133.36M |
| Property, plant & equipment | $578.00K | $898.00K | $1.24M | $1.27M | $382.00K | $623.69K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $61.88M | $97.19M | $81.64M | $116.19M | $149.54M | $134.73M |
| Accounts payable | $8.09M | $4.82M | $1.97M | $1.96M | $1.44M | $1.37M |
| Total current liabilities | $16.39M | $13.43M | $10.44M | $7.81M | $6.56M | $6.12M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $16.50M | $14.24M | $11.90M | $9.85M | $9.13M | $6.57M |
| Retained earnings | -$430.03M | -$384.18M | -$339.54M | -$298.10M | -$259.81M | -$231.50M |
| Total equity | $45.39M | $82.95M | $69.74M | $106.34M | $140.42M | $128.16M |